Evidence map›Paper›PMID 37307874›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2023

Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations.

John M Gross, Raul Perret, Jean Michel Coindre, Francois Le Loarer, Michael Michal, Michal Michal, Markku Miettinen, Chantal E McCabe, Asha A Nair, Amy A Swanson and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

John M GrossDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Raul PerretDepartment of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France.
Jean Michel CoindreDepartment of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France; University of Bordeaux, Talence, France.
Francois Le LoarerDepartment of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France; Bordeaux Institute of Oncology, Université de Bordeaux, Institut Bergonié, Bordeaux, France; University of Bordeaux, Talence, France.
Michael MichalDepartment of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Michal MichalDepartment of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Markku MiettinenLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Chantal E McCabeDepartment of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, Minnesota.
Asha A NairDepartment of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, Minnesota.
Amy A SwansonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Judith J ThangaiahDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Jorge Torres-MoraDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Angelo BonadioDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Lysandra VoltaggioDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Jonathan I EpsteinDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Sounak GuptaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Andrew L FolpeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
J Kenneth SchoolmeesterDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida. Electronic address: schoolmeester.j@mayo.edu.
Mayo Clinic · USJohns Hopkins University · USUniversité de Bordeaux · FRCharles University · CZMayo Clinic in Florida · USJacksonville College · USNational Institutes of Health · USUniversity of Pisa · IT

Funding

Genreal Surgical PathologyZIDBC011291 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MIETTINEN, MARKKU · 2010 to 2025
$30.3M
Intramural NIH HHS ZID BC011291
6 · The paper itself

Abstract

Lipoblastoma-like tumor (LLT) is a benign soft tissue tumor demonstrating mixed morphologic features of lipoblastoma, myxoid liposarcoma, and spindle cell lipoma but lacking genetic alterations associated with those tumors. LLT was originally thought to be specific to the vulva but has since been reported in the paratesticular region. The morphologic features of LLT overlap with those of "fibrosarcoma-like lipomatous neoplasm" (FLLN), a rare, indolent adipocytic neoplasm considered by some to form part of the spectrum of atypical spindle cell and pleomorphic lipomatous tumor. We compared the morphologic, immunohistochemical, and genetic features of 23 tumors previously classified as LLT (n = 17) and FLLN (n = 6). The 23 tumors occurred in 13 women and 10 men (mean age, 42 years; range, 17 to 80 years). Eighteen (78%) cases arose in the inguinogenital region, whereas 5 tumors (22%) involved noninguinogenital soft tissue, including the flank (n = 1), shoulder (n = 1), foot (n = 1), forearm (n = 1), and chest wall (n = 1). Microscopically, the tumors were lobulated and septated, with variably collagenized fibromyxoid stroma, prominent thin-walled vessels, scattered univacuolated or bivacuolated lipoblasts, and a minor component of mature adipose tissue. Using immunohistochemistry, 5 tumors (42%) showed complete RB1 loss, with partial loss in 7 cases (58%). RNA sequencing, chromosomal microarray, and DNA next-generation sequencing study results were negative for significant alterations. There were no clinical, morphologic, immunohistochemical, or molecular genetic differences between cases previously classified as LLT or FLLN. Clinical follow-up (11 patients [48%]; range, 2-276 months; mean, 48.2 months) showed all patients were alive without disease, and only one patient had experienced a single local recurrence. We conclude that LLT and FLLN represent the same entity, for which "LLT" seems most appropriate. LLT may occur in either sex and any superficial soft tissue location. Careful morphologic study and appropriate ancillary testing should allow for the distinction of LLT from its potential mimics.

Indexed as

FibrosarcomaLipoblastomaLipomaLiposarcomaLiposarcoma, MyxoidAdultBiomarkers, TumorFemaleHumansMaleMolecular BiologyBiomarkers, Tumorfibrosarcoma-like lipomatous neoplasmlipoblastoma-like tumorlipomatous tumormyxoid sarcoma

Identifiers

PMID37307874
PMCPMC10530403
OpenAlexW4380148787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.